Condition
Paralytic Lagophthalmos
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Recruiting2
Suspended1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03848260Not ApplicableSuspendedPrimary
A Real-Time Magnetic Device Prototype for Temporary Management of Paralytic Lagophthalmos
NCT06895902Early Phase 1Recruiting
Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy
NCT06291818Not ApplicableRecruitingPrimary
Self-Adhering Magnetic Device to Treat Corneal Exposure
NCT04944498Not ApplicableCompletedPrimary
Modified Tarsorrhaphy vs Gold Weight Implant for Paralytic Lagophthalmos in Leprosy Patients
Showing all 4 trials